Inventor · disambiguated record
Till Strowig
Also filed as: STROWIG TILL
13 granted patents·6 pending applications·103 citations·filing 2011–2024
91Inventor score
Files withREGENERON PHARMA14ELINAV ERAN1FLAVELL RICHARD A1HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH1REGENEREN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
19 records- 0197US10433527B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Oct 8, 2019·13 cites·12 claims
- 0296US9986724B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Jun 5, 2018·17 cites·14 claims
- 0395US9901082B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Feb 27, 2018·17 cites·6 claims
- 0494US9820476B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Nov 21, 2017·12 cites·15 claims
- 0593US9402377B2Human SIRPAalpha transgenic animals and their methods of useFLAVELL RICHARD A·Filed 2011·Granted Aug 2, 2016·33 cites·10 claims
- 0689US11026408B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jun 8, 2021·2 cites·17 claims
- 0789US2025072405A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0887US10561126B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Feb 18, 2020·5 cites·22 claims
- 0986US2024099278A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1083US10123518B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·3 cites·28 claims
- 1177US12127537B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Oct 29, 2024·0 cites·18 claims
- 1277US2023292721A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1374US11778995B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Oct 10, 2023·0 cites·11 claims
- 1474US9839208B2Human SIRPα transgenic mice and their methods of useUNIV YALE·Filed 2016·Granted Dec 12, 2017·1 cites·17 claims
- 1569US10785968B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2017·Granted Sep 29, 2020·0 cites·10 claims
- 1664US2018020647A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 1762US11576356B2Genetically modified non-human animals and methods of use thereofREGENEREN PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 1858US2024041950A1Decolonization of enterobacteria, such as klebsiella pneumoniae, from the gut using strains of klebsiella oxytocaHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2021·Application pending·0 cites
- 1941US2014377278A1Compositions and Methods for Assessing and Treating Inflammatory Diseases and DisordersELINAV ERAN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Till Strowig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →